Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia
- PMID: 17244685
- DOI: 10.1182/blood-2006-01-031781
Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia
Abstract
The Runt domain transcription factor AML1/RUNX1 is essential for the generation of hematopoietic stem cells and is the most frequent target of chromosomal translocations associated with leukemia. Here, we present a new AML1 translocation found in a patient with acute myeloid leukemia M4 with t(8;21)(q24;q22) at the time of relapse. This translocation generated an in-frame chimeric gene consisting of the N-terminal portion of AML1, retaining the Runt domain, fused to the entire length of TRPS1 on the C-terminus. TRPS1 encodes a putative multitype zinc finger (ZF) protein containing 9 C2H2 type ZFs and 1 GATA type ZF. AML1-TRPS1 stimulated proliferation of hematopoietic colony-forming cells and repressed the transcriptional activity of AML1 and GATA-1 by 2 different mechanisms: competition at their cognate DNA-binding sites and physical sequestrations of AML1 and GATA-1, suggesting that simultaneous deregulation of AML1 and GATA factors constitutes a basis for leukemogenesis.
Similar articles
-
Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts.Blood. 2007 Aug 1;110(3):799-805. doi: 10.1182/blood-2006-11-019265. Epub 2007 Apr 5. Blood. 2007. PMID: 17412887 Free PMC article. Review.
-
ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.Blood. 1996 Sep 1;88(5):1813-23. Blood. 1996. PMID: 8781439
-
Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.Leukemia. 1997 Apr;11 Suppl 3:273-8. Leukemia. 1997. PMID: 9209363
-
The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.Haematologica. 1997 May-Jun;82(3):364-70. Haematologica. 1997. PMID: 9234595 Review.
-
PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).Genes Chromosomes Cancer. 2004 Aug;40(4):365-70. doi: 10.1002/gcc.20050. Genes Chromosomes Cancer. 2004. PMID: 15188461
Cited by
-
PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.Blood. 2008 Nov 1;112(9):3777-87. doi: 10.1182/blood-2008-01-134122. Epub 2008 Aug 11. Blood. 2008. PMID: 18695000 Free PMC article.
-
Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7749-E7758. doi: 10.1073/pnas.1613859113. Epub 2016 Nov 14. Proc Natl Acad Sci U S A. 2016. PMID: 27849608 Free PMC article.
-
A central role for TRPS1 in the control of cell cycle and cancer development.Oncotarget. 2014 Sep 15;5(17):7677-90. doi: 10.18632/oncotarget.2291. Oncotarget. 2014. PMID: 25277197 Free PMC article.
-
WNT inhibitory factor 1 (WIF1) is a novel fusion partner of RUNX family transcription factor 1 (RUNX1) in acute myeloid leukemia with t(12;21)(q14;q22).J Hematop. 2024 Dec;17(4):245-249. doi: 10.1007/s12308-024-00597-4. Epub 2024 Jul 27. J Hematop. 2024. PMID: 39066949
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical